Tracon Pharmaceuticals, Inc.;Health Research, Inc.
发明人:
Charles P. Theuer,Ben K. Seon
申请号：
US16112304
公开号：
US20180371072A1
申请日:
2018.08.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present application relates to compositions of chimeric anti-endoglin antibodies and anti-VEGF agents. Another aspect relates to the use of chimeric anti-endoglin antibodies and Bevacizumab. Another aspect relates to the use of the compositions to inhibit VEGF induced sprouting. Another aspect relates to the use of the compositions to inhibit angiogenesis.
